Cartesian Therapeutics Inc (NAS:RNAC)
$ 35.64 -0.36 (-1%) Market Cap: 634.25 Mil Enterprise Value: 545.21 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 50/100

Selecta Biosciences Inc at Raymond James Human Health Innovation Conference (Virtual) Transcript

Jun 23, 2021 / 04:00PM GMT
Release Date Price: $137.1 (+0.44%)
Dane Leone
Raymond James - Analyst

Greetings, everyone. Welcome to the next session here at the 2021 Raymond James Human Health Innovation Conference. This is Dane, one of the senior biotech analysts on the Ray J team. For this session, we're going to have a presentation from Selecta Bio with Carsten, the CEO, presenting for the company. Welcome, pleasure to have you here at our conference.

Carsten Brunn
Selecta Biosciences, Inc. - President and CEO

Great. Thank you, Dane, for the opportunity. I will just share my slides here.

Dane Leone
Raymond James - Analyst

Excellent. So, for those of the audience that might not know you as well, maybe you can just give a brief background on yourself, and then dive into what the Selecta team has been working on.

Carsten Brunn
Selecta Biosciences, Inc. - President and CEO

Yes, absolutely. Yes, so my name is Carsten Brunn, I'm the CEO at Selecta. I joined in December 2018, previously worked both in biotech and big pharma. And I

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot